CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 444,325	$ 205,156
Interest bearing deposits with banks	503,622	1,844,764
Investment securities:
Equity securities	48,731	36,473
Trading debt securities	13,438	38,130
Available for sale debt securities	1,261,397	1,128,809
Held to maturity debt securities (net of allowance for credit losses of $1,646 at December 31, 2022 and $1,165 at December 31, 2021)	3,827,338	2,667,532
Total investment securities	5,150,904	3,870,944
Loans held for sale, at fair value	18,118	139,516
Loans	46,917,200	34,153,657
Less: Allowance for loan losses	(458,655)	(359,202)
Net loans	46,458,545	33,794,455
Premises and equipment, net	358,556	326,306
Lease right of use assets	306,352	259,117
Bank owned life insurance	717,177	566,770
Accrued interest receivable	196,606	96,882
Goodwill	1,868,936	1,459,008
Other intangible assets, net	197,456	70,386
Other assets	1,242,152	813,139
Total Assets	57,462,749	43,446,443
Deposits:
Non-interest bearing	14,463,645	11,675,748
Interest bearing:
Savings, NOW and money market	23,616,812	20,269,620
Time	9,556,457	3,687,044
Total deposits	47,636,914	35,632,412
Short-term borrowings	138,729	655,726
Long-term borrowings	1,543,058	1,423,676
Junior subordinated debentures issued to capital trusts	56,760	56,413
Lease liabilities	358,884	283,106
Accrued expenses and other liabilities	1,327,602	311,044
Total Liabilities	51,061,947	38,362,377
Shareholders’ Equity
Common stock (no par value, authorized 650,000,000 shares; issued 507,896,910 shares at December 31, 2022 and 423,034,027 shares at December 31, 2021)	178,185	148,482
Surplus	4,980,231	3,883,035
Retained earnings	1,218,445	883,645
Accumulated other comprehensive loss	(164,002)	(17,932)
Treasury stock, at cost (1,522,432 common shares at December 31, 2022 and 1,596,959 common shares at December 31, 2021)	(21,748)	(22,855)
Total Shareholders’ Equity	6,400,802	5,084,066
Total Liabilities and Shareholders’ Equity	57,462,749	43,446,443
Series A Preferred Stock
Shareholders’ Equity
Preferred stock, no par value; authorized 50,000,000 shares:	111,590	111,590
Series B Preferred Stock
Shareholders’ Equity
Preferred stock, no par value; authorized 50,000,000 shares:	$ 98,101	$ 98,101